These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1716 related items for PubMed ID: 21556952

  • 1. Nodal metastasis from locally advanced esophageal cancer: how neoadjuvant therapy modifies their frequency and distribution.
    Castoro C, Scarpa M, Cagol M, Ruol A, Cavallin F, Alfieri R, Zanchettin G, Rugge M, Ancona E.
    Ann Surg Oncol; 2011 Dec; 18(13):3743-54. PubMed ID: 21556952
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Clinical T2-T3N0M0 esophageal cancer: the risk of node positive disease.
    Stiles BM, Mirza F, Coppolino A, Port JL, Lee PC, Paul S, Altorki NK.
    Ann Thorac Surg; 2011 Aug; 92(2):491-6; discussion 496-8. PubMed ID: 21704291
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Impact of circumferential resection margin distance on locoregional recurrence and survival after chemoradiotherapy in esophageal squamous cell carcinoma.
    Chao YK, Yeh CJ, Chang HK, Tseng CK, Chu YY, Hsieh MJ, Wu YC, Liu HP.
    Ann Surg Oncol; 2011 Feb; 18(2):529-34. PubMed ID: 20697822
    [Abstract] [Full Text] [Related]

  • 8. Improved outcomes in the management of esophageal cancer with the addition of surgical resection to chemoradiation therapy.
    McKenzie S, Mailey B, Artinyan A, Metchikian M, Shibata S, Kernstine K, Kim J.
    Ann Surg Oncol; 2011 Feb; 18(2):551-8. PubMed ID: 20839062
    [Abstract] [Full Text] [Related]

  • 9. Influence of neoadjuvant chemoradiation on the number and size of analyzed lymph nodes in esophageal cancer.
    Bollschweiler E, Besch S, Drebber U, Schröder W, Mönig SP, Vallböhmer D, Baldus SE, Metzger R, Hölscher AH.
    Ann Surg Oncol; 2010 Dec; 17(12):3187-94. PubMed ID: 20585867
    [Abstract] [Full Text] [Related]

  • 10. Locally advanced esophageal adenocarcinoma: response to neoadjuvant chemotherapy and survival predicted by ([18F])FDG-PET/CT.
    Kauppi JT, Oksala N, Salo JA, Helin H, Karhumäki L, Kemppainen J, Sihvo EI, Räsänen JV.
    Acta Oncol; 2012 May; 51(5):636-44. PubMed ID: 22208782
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pathologic response after neoadjuvant therapy is the major determinant of survival in patients with esophageal cancer.
    Meredith KL, Weber JM, Turaga KK, Siegel EM, McLoughlin J, Hoffe S, Marcovalerio M, Shah N, Kelley S, Karl R.
    Ann Surg Oncol; 2010 Apr; 17(4):1159-67. PubMed ID: 20140529
    [Abstract] [Full Text] [Related]

  • 15. Oncologic Outcomes According to Remnant Lymph Node Metastases in Pathologic T0 (ypT0) Esophageal Squamous Cell Carcinoma Following Prospective Neoadjuvant Therapy and Surgery.
    Cho HJ, Kim YH, Kim HR, Kim DK, Park SI, Kim JH, Kim SB.
    Ann Surg Oncol; 2015 Apr; 22(6):1851-7. PubMed ID: 25344308
    [Abstract] [Full Text] [Related]

  • 16. Lymph node harvest in esophageal cancer after neoadjuvant chemoradiotherapy.
    Shridhar R, Hoffe SE, Almhanna K, Weber JM, Chuong MD, Karl RC, Meredith K.
    Ann Surg Oncol; 2013 Sep; 20(9):3038-43. PubMed ID: 23625142
    [Abstract] [Full Text] [Related]

  • 17. The usefulness of neoadjuvant chemoradiation therapy for locally advanced esophageal cancer with multiple lymph-node metastases.
    Okumura H, Uchikado Y, Omoto I, Kita Y, Sasaki K, Arigami T, Uenosono Y, Matsushita D, Hiraki Y, Owaki T, Ishigami S, Natsugoe S.
    Ann Surg Oncol; 2014 Sep; 21(9):2845-9. PubMed ID: 24728820
    [Abstract] [Full Text] [Related]

  • 18. Detection of interval distant metastases: clinical utility of integrated CT-PET imaging in patients with esophageal carcinoma after neoadjuvant therapy.
    Bruzzi JF, Swisher SG, Truong MT, Munden RF, Hofstetter WL, Macapinlac HA, Correa AM, Mawlawi O, Ajani JA, Komaki RR, Fukami N, Erasmus JJ.
    Cancer; 2007 Jan 01; 109(1):125-34. PubMed ID: 17146785
    [Abstract] [Full Text] [Related]

  • 19. Resectable esophageal carcinoma: local control with neoadjuvant chemotherapy and radiation therapy.
    Chidel MA, Rice TW, Adelstein DJ, Kupelian PA, Suh JH, Becker M.
    Radiology; 1999 Oct 01; 213(1):67-72. PubMed ID: 10540642
    [Abstract] [Full Text] [Related]

  • 20. Outcomes of preoperative chemotherapy with docetaxel, cisplatin, and 5-fluorouracil followed by esophagectomy in patients with resectable node-positive esophageal cancer.
    Watanabe M, Baba Y, Yoshida N, Ishimoto T, Nagai Y, Iwatsuki M, Iwagami S, Baba H.
    Ann Surg Oncol; 2014 Sep 01; 21(9):2838-44. PubMed ID: 24715216
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 86.